EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Antileishmanial Activity of Some Benzimidazole Derivatives Using In Vitro and In Silico Techniques

Mustafa Eser iD, İbrahim Çavuş, Aybüke Züleyha Kaya iD, Asaf Evrim Evren iD, Leyla Yurttaş

Veterinary Sciences · 05.06.2025 · 12 (6) · 550

DOI: 10.3390/vetsci12060550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Sciences, online erschienen am 05.06.2025. Verfasst von Mustafa Eser und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Türkiye. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anadolu University Scientific Research Project, Eskisehir, Turkey.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzimidazole derivatives are well known for their anthelmintic activity. Investigating the potential efficacy of new derivatives of this class against various parasites is essential to identify novel drug candidates. For this purpose, an in-house molecular database was screened, and four benzimidazole-based molecules were chosen to evaluate antiprotozoal activity. The compounds (K1–K4) had been previously synthesized through a four-step procedure. The potential in vitro cytotoxic properties of the compounds were assessed against the Leishmania (L.) major strain and L929 mouse fibroblast cells. The tests indicated that K1 (3-Cl phenyl) demonstrated an antileishmanial effect (IC50 = 0.6787 µg/mL) and cytotoxicity at elevated concentrations (CC50 = 250 µg/mL) in healthy cells. These findings were comparable to those of AmpB. The antileishmanial activity values were determined as follows: K2; 8.89 µg/mL, K3; 45.11 µg/mL, K4; and 69.19 µg/mL. The CC50 values were determined as follows: K2, 63 µg/mL; K3; 0.56 µg/mL; and K4, 292 µg/mL. Molecular docking and dynamic simulations were conducted to elucidate the potential mechanisms of action of the test substances. In silico investigations indicated interactions between the compounds and the active site of pteridine reductase 1 (PTR1), which is a biosynthetic enzyme essential for parasite proliferation. N-alkyl benzimidazole-based compounds exhibit potential inhibitory activity against L. (L.) major promastigotes. Therefore, these findings suggest that in vivo evaluation is warranted, and structural modifications may lead to the identification of more effective antileishmanial agents.

Schlagwörter

Stichwörter der Autor:innen

Leishmania majorantileismanial activitybenzimidazole derivatesin silicoin vitropteridine reductase 1

Autor:innen und Institutionen

  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Türkiye.
  • Department of Parasitology, Faculty of Medicine, Manisa Celal Bayar University, Manisa 45030, Türkiye.
  • Department of Pharmaceutical Chemistry, Institute of Graduate Education, Anadolu University, Eskişehir 26470, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Türkiye.

ORCID-Profile: Mustafa Eser, Aybüke Züleyha Kaya, Asaf Evrim Evren

Förderung

  • Anadolu University Scientific Research Project, Eskisehir, Turkey

Zitieren

APA

Eser, M., Çavuş, İ., Kaya, A. Z., Evren, A. E., & Yurttaş, L. (2025). Evaluation of the Antileishmanial Activity of Some Benzimidazole Derivatives Using In Vitro and In Silico Techniques. Veterinary Sciences, 12(6), 550. https://doi.org/10.3390/vetsci12060550

Vancouver

Eser M, Çavuş İ, Kaya AZ, Evren AE, Yurttaş L. Evaluation of the Antileishmanial Activity of Some Benzimidazole Derivatives Using In Vitro and In Silico Techniques. Veterinary Sciences. 2025;12(6):550. doi:10.3390/vetsci12060550

BibTeX
@article{Eser2025,
  author = {Eser, Mustafa and Çavuş, İbrahim and Kaya, Aybüke Züleyha and Evren, Asaf Evrim and Yurttaş, Leyla},
  title = {Evaluation of the Antileishmanial Activity of Some Benzimidazole Derivatives Using In Vitro and In Silico Techniques},
  journal = {Veterinary Sciences},
  year = {2025},
  volume = {12},
  number = {6},
  pages = {550},
  doi = {10.3390/vetsci12060550}
}
Kostenlos starten →